Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001610520-25-000006·Amneal Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 per share · CUSIP: 03168L105
Event date: 2024-12-31
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- UBS Group AG
Shares: Unavailable · Class: Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001610520-25-000006
- Form type
- SCHEDULE 13G/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership